Insmed Incorporated
corporate_fare Company Profile
Insmed Incorporated (NASDAQ:INSM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 24 items for INSM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 9/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for INSM spans 10-Q, 8-K, 144, DEF 14A.
Recent high-impact activity:
- Sanofi Weighs Takeover Bid for Insmed, Bloomberg Reports
- Insmed Lifts 2026 BRINSUPRI Guidance to $1.35–1.40B After $524.4M Q3
- Insmed Beats Q3 Revenue Estimates and Lifts Full-Year Guidance Range
- Insmed Q3 Revenue Jumps 268% to $524M as BRINSUPRI Hits $398M in US Sales
- Insmed Q3 Revenue Hits $524.4M as BRINSUPRI Grows 29% Sequentially, Guidance Raised
Financial Snapshot
Short Interest & Short Volume
3.56 days to coverFINRA reported short interest of 14,080,405 shares in INSM as of the October 30, 2026 settlement, a 4.5% increase from the prior period — about 3.6 days to cover at its recent average daily volume. On November 20, 2026, 45.1% of INSM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.